Heme
Study Name: CSL624_2001
- Cancer Stage: N/A
- Key Inclusion: HFE+ HH
- Description: CSL624_2001 / A Phase 2, Multicenter, Randomized, Placebo-controlled, Double-blind Study of Vamifeport in Adult Subjects with HFE-related Hereditary Hemochromatosis
- Study Number: N/A
- NCT#: NCT07332091